首页 | 本学科首页   官方微博 | 高级检索  
检索        

281例骨髓增生异常综合征患者染色体核型分析及临床意义的研究
引用本文:韩秀蕊,杨娣娣,赵 园,张丽洁,李艳春,王九菊,翟欣辉,魏绪仓,周家琛.281例骨髓增生异常综合征患者染色体核型分析及临床意义的研究[J].现代检验医学杂志,2015,0(4):91-92.
作者姓名:韩秀蕊  杨娣娣  赵 园  张丽洁  李艳春  王九菊  翟欣辉  魏绪仓  周家琛
作者单位:1.陕西省人民医院血液病研究室,西安 710068; 2.大连医科大学,辽宁大连 116044
摘    要:目的 探讨骨髓增生异常综合征(MDS)患者染色体核型异常特征及其与临床预后的关系。方法 采用染色体常规G显带技术,对281例MDS患者进行细胞遗传学核型分析。结果 281例MDS患者中,染色体异常核型检出率48.75%(137/281),其中单纯染色体数目异常43.07%(59/137),单纯染色体结构异常者31.39%(43/137),同时有数目与结构异常者25.54%(35/137)。MDS亚型中,RAEB-2异常核型检出率为63.41%(26/41),RAEB-1为58.73%(37/63),RCMD 39.2%(49/125),RAS 15.38%(2/13),RA 22.58%(7/31)。RA,RAS异常核型检出率明显低于RAEB-1和RAEB-2(P<0.01),RAEB-1和RAEB-2检出率高于RCMD(P<0.05)。出现频率较高的染色体畸变依次为+8,-7/7q-,-20/20q-,复杂异常核型,染色体易位,i(17),-Y,+21等。随访的159例MDS患者中核型正常者68例,中位生存时间为39个月,核型异常者91例中位生存期21个月的,前者明显长于后者(P<0.05),分析白血病转化率,核型异常者(35.5%),明显高于核型正常者(10.3%)(P<0.01),其中以复杂核型、-7/7q-核型较易转为白血病。结论 MDS系克隆性恶性血液病,具有高度异质性,染色体核型检查对MDS的正确诊断、分型和预后判断具有重要意义。

关 键 词:骨髓增生异常综合征  染色体核型  细胞遗传学

Study on Chromosome Karyotype and Its Clinical Significance in 281 Cases of Myelodysplastic Syndromes
HAN Xiu-rui,YANG Di-di,ZHAO Yuan,ZHANGLi-jie,LI Yan-chun,WANG Jiu-ju,ZHAI Xin-hui,WEI Xu-cang,ZHOU Jia-chen.Study on Chromosome Karyotype and Its Clinical Significance in 281 Cases of Myelodysplastic Syndromes[J].Journal of Modern Laboratory Medicine,2015,0(4):91-92.
Authors:HAN Xiu-rui  YANG Di-di  ZHAO Yuan  ZHANGLi-jie  LI Yan-chun  WANG Jiu-ju  ZHAI Xin-hui  WEI Xu-cang  ZHOU Jia-chen
Institution:1.Department of Hematology,Shaanxi Provincial People's Hospital, Xi'an 710068,China; 2.Dalian Medical University,Liaoning Dalian 116044,China
Abstract:Objective To explore the abnormal karyotype characteristics of myelodysplastic syndrome(MDS)patients and their correlation with clinical prognosis.Methods Analyzed the karyotypes of 281 MDS patients by use of G-banding technique.Results Through analysis of the karyotypes of 281 MDS patients,found that the percentage of abnormal karyotypes was 48.75%(137/281),among 137 patientswith abnormal karyotypes,43.07%(59 cases)presented with numerical aberration,31.39%(43 cases)with structural aberration,and 25.54%(35 cases)with both numerical and structural abnormalities.As for MDS subtypes,the occurrence rate of abnormal karyotype was 63.41%(26/41)in RAEB-2,58.73%(37/63)in RAEB-1,39.2%(49/125)in RCMD,15.38%(2/13)in RAS and 22.58%(7/31)in RA.The rates of abnormal karyotype in RAEB-1 and RAEB-2 were significantly higherthan that in RA and RAS(P<0.01),and in RCMD(P<0.05).The frequent abnormal karyotypes were as follows:+8,-7/7q-,-20/20q-,complex karyotypes chromosomal translocation,i(17),-Y and +21.The follow-up study of 159 MDS patients indicated that the median survival time was 39 months for 68 patients with normal karyotypes and 21 months for 91 patients with abnormal karyotypes,the former was significantly prolonged than the latter(P<0.05).As far as the leukemia transition rate was concerned,the patients with aberrant karyotypes(35.5%)were significantly higher than that with normal karyotypes(10.3%)(P<0.01),among them,the cases with complex karyotypes and -7/7q- more easily transit into leukemia.Conclusion MDS was one kind of clonal hematological malignancy with high heterogeneity.Chromosomal karyotype test plays an important role in the correct diagnosis,typing and prognosis evaluation of MDS.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号